Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis

BackgroundTo assess the efficacy and safety of various TCMIs treatments for COPD using network meta-analysis, providing evidence and guidance for clinical practice.MethodsWe will search 7 databases for randomized controlled trials of TCMI for the COPD, including PubMed, the Cochrane Library, EMbase,...

Full description

Saved in:
Bibliographic Details
Main Authors: Shan An, Hong-Yan Cai
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1512729/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849717422486978560
author Shan An
Hong-Yan Cai
author_facet Shan An
Hong-Yan Cai
author_sort Shan An
collection DOAJ
description BackgroundTo assess the efficacy and safety of various TCMIs treatments for COPD using network meta-analysis, providing evidence and guidance for clinical practice.MethodsWe will search 7 databases for randomized controlled trials of TCMI for the COPD, including PubMed, the Cochrane Library, EMbase, China National Knowledge Infrastructure, China Biological Medicine, Chinese Scientific Journals Database, and Wan-fang databases, from the date of the establishment of each database to October 31, 2021. The network meta-analysis will be implemented through Aggregate Data Drug Information System 1.16.8 and Stata13.0 software. Pulmonary function included forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and FEV1/FVC will be the primary outcomes, FEV1 as a percentage of the estimated value, maximal voluntary ventilation (MVV), MVV as a percentage of the estimated value, 6 min walking distance, The St.ResultsA total of seven appropriate studies were identified, encompassing 490 patients. The quality of the literature was satisfactory, with no significant publication bias detected. The effectiveness rate for patients receiving a combination of TCM and Western Medicine (WM) compared to those on WM alone was evaluated as an odds ratio (OR), with statistical testing yielding Z = 6.09. For PO2 levels post-treatment, the mean difference (MD) was reported as 5.92.ConclusionThe results of this study will evaluate the efficacy and safety of TCMI in the treatment of COPD, and provide decision-making references for future clinical and scientific research.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251047046, identifier CRD420251047046.
format Article
id doaj-art-78a5c09eb6d043a4b6fa8c9523e88801
institution DOAJ
issn 2296-858X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-78a5c09eb6d043a4b6fa8c9523e888012025-08-20T03:12:39ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-05-011210.3389/fmed.2025.15127291512729Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysisShan An0Hong-Yan Cai1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, ChinaPulmonology Department, The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine, Changchun, ChinaBackgroundTo assess the efficacy and safety of various TCMIs treatments for COPD using network meta-analysis, providing evidence and guidance for clinical practice.MethodsWe will search 7 databases for randomized controlled trials of TCMI for the COPD, including PubMed, the Cochrane Library, EMbase, China National Knowledge Infrastructure, China Biological Medicine, Chinese Scientific Journals Database, and Wan-fang databases, from the date of the establishment of each database to October 31, 2021. The network meta-analysis will be implemented through Aggregate Data Drug Information System 1.16.8 and Stata13.0 software. Pulmonary function included forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and FEV1/FVC will be the primary outcomes, FEV1 as a percentage of the estimated value, maximal voluntary ventilation (MVV), MVV as a percentage of the estimated value, 6 min walking distance, The St.ResultsA total of seven appropriate studies were identified, encompassing 490 patients. The quality of the literature was satisfactory, with no significant publication bias detected. The effectiveness rate for patients receiving a combination of TCM and Western Medicine (WM) compared to those on WM alone was evaluated as an odds ratio (OR), with statistical testing yielding Z = 6.09. For PO2 levels post-treatment, the mean difference (MD) was reported as 5.92.ConclusionThe results of this study will evaluate the efficacy and safety of TCMI in the treatment of COPD, and provide decision-making references for future clinical and scientific research.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD420251047046, identifier CRD420251047046.https://www.frontiersin.org/articles/10.3389/fmed.2025.1512729/fullchronic obstructive pulmonary disease (COPD)traditional Chinese medicineinjectionsmeta-analysissystematic review
spellingShingle Shan An
Hong-Yan Cai
Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
Frontiers in Medicine
chronic obstructive pulmonary disease (COPD)
traditional Chinese medicine
injections
meta-analysis
systematic review
title Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
title_full Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
title_fullStr Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
title_full_unstemmed Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
title_short Efficacy and safety of traditional Chinese medicine in the treatment of chronic pulmonary diseases: a systematic review and meta-analysis
title_sort efficacy and safety of traditional chinese medicine in the treatment of chronic pulmonary diseases a systematic review and meta analysis
topic chronic obstructive pulmonary disease (COPD)
traditional Chinese medicine
injections
meta-analysis
systematic review
url https://www.frontiersin.org/articles/10.3389/fmed.2025.1512729/full
work_keys_str_mv AT shanan efficacyandsafetyoftraditionalchinesemedicineinthetreatmentofchronicpulmonarydiseasesasystematicreviewandmetaanalysis
AT hongyancai efficacyandsafetyoftraditionalchinesemedicineinthetreatmentofchronicpulmonarydiseasesasystematicreviewandmetaanalysis